20-Hydroxyeicosatetraenoic acid
A metabolite of arachidonic acid
20-Hydroxyeicosatetraenoic acid (20-HETE) is a metabolite of arachidonic acid, an important polyunsaturated fatty acid in the human body. It is produced by the action of cytochrome P450 enzymes, specifically the CYP4A and CYP4F subfamilies. 20-HETE plays a significant role in the regulation of vascular tone, renal function, and blood pressure.
Biosynthesis[edit]
20-HETE is synthesized from arachidonic acid through the action of cytochrome P450 enzymes. These enzymes hydroxylate arachidonic acid at the omega-terminus, specifically at the 20th carbon, to produce 20-HETE. The CYP4A and CYP4F subfamilies are primarily responsible for this conversion.
Physiological roles[edit]
20-HETE is involved in various physiological processes:
- Vascular tone regulation: 20-HETE acts as a potent vasoconstrictor in the cerebral, renal, and coronary circulations. It modulates the activity of ion channels and smooth muscle contraction, influencing blood flow and pressure.
- Renal function: In the kidneys, 20-HETE regulates sodium and water excretion, affecting glomerular filtration rate and tubular reabsorption. It plays a role in renal autoregulation and blood pressure control.
- Inflammation and cell proliferation: 20-HETE has been implicated in inflammatory responses and cell proliferation, influencing processes such as angiogenesis and tumor growth.
Pathophysiological implications[edit]
Abnormal levels of 20-HETE have been associated with various diseases and conditions:
- Hypertension: Elevated 20-HETE levels have been linked to the development of hypertension, particularly in salt-sensitive individuals.
- Stroke and cardiovascular diseases: Due to its role in vascular tone regulation, 20-HETE is implicated in the pathogenesis of stroke and other cardiovascular diseases.
- Cancer: 20-HETE has been shown to promote tumor growth and metastasis in certain types of cancer, making it a potential target for therapeutic intervention.
Research and therapeutic potential[edit]
Research into 20-HETE is ongoing, with studies exploring its potential as a therapeutic target. Inhibitors of 20-HETE synthesis or action are being investigated for their potential to treat hypertension, stroke, and cancer.
Related pages[edit]
Gallery[edit]
-
Chemical structure of 20-HETE
20-Hydroxyeicosatetraenoic acid[edit]
-
Chemical structure of 20-Hydroxyeicosatetraenoic acid
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
